close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Herbert Newton

LOCATION OF PRACTICE
University Hospitals Seidman Cancer Center
NPI Number
1770667164
ABOUT

Herbert Newton, MD, FAAN, is a neuro-oncologist and Medical Director of the Brain Tumor Center at University Hospitals Seidman Cancer Center. His interests include clinical neuro-oncology, chemotherapy, molecular biology, molecular therapeutics, and clinical trials.

Dr. Herbert Newton profile image

Published Articles

"Tortured Both Night and Day": A Possible Seventeenth-Century Case of Noma.- 2026 Mar 19
Seizures in brain tumor hospitalizations in the United States.- 2025
Comparative analyses for plant virus-based cancer immunotherapy drug development.- 2025 Jul 22
Immune Responses to Human Papillomavirus After Infection and Vaccination.- 2026
Phase 1 Trial of Withania somnifera Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [(18)F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials.- 2026 Jan-Dec
Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral-Like Immunomodulatory Responses and Potent Adjuvant Activity.- 2026 Jan 7
Intralysosomal pathogens differentially influence the proteolytic potential of their niche.- 2026 Feb 10
Mobile crisis effectiveness: a systematic review and associated functions and forms framework.- 2025 Dec 9
Systematic Discovery of Pathogen Effector Functions across Human Pathogens and Pathways.- 2025 Nov 17
A service evaluation of Early Positive Approaches to Support (E-PAtS): Comparing online versus in-person group outcomes.- 2025 Nov 28

Clinical Trials

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases

My Patient Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider